Prostate Screening (PSA)

Self-pay prostate screening at the Zlín poliklinika collection point. Total PSA is the established blood marker used to screen for prostate problems; free PSA and the advanced proPSA/phi (Prostate Health Index) refine risk assessment and can help reduce unnecessary biopsies. No referral required; payment at the draw.

Prostate cancer risk rises sharply after age 50 and is a leading cause of cancer death in men, so early detection while disease is confined to the gland has real value. Vaše laboratoře offers the relevant blood markers on a self-pay basis. **Markers available:** - Total PSA (281 Kč, the default) — prostate-specific antigen, the long-established screening marker. It can be raised by non-cancerous causes too, such as prostate inflammation, urinary infection or an enlarged prostate. - Free PSA (fPSA, 428 Kč) — the ratio of free to total PSA helps distinguish benign causes from those needing further investigation. - proPSA / phi (1,728 Kč) — the Prostate Health Index combines total PSA, free PSA and proPSA into a single score that reflects the likelihood of significant cancer and gives information on how aggressive a tumour may be, which can help avoid repeated, sometimes unnecessary, prostate biopsies. This advanced marker is not covered by public insurance and is offered self-pay. **How it works:** Attend the Zlín poliklinika collection point during morning collection hours. A laboratory nurse takes a venous sample and payment is made at the draw; results return through the laboratory's standard channels. PSA results should always be interpreted with a urologist, who decides on any further steps. **Who it suits:** Men over 50, younger men with a family history of prostate cancer, and those with a previously raised PSA wanting a more refined assessment before deciding on biopsy.